Related references
Note: Only part of the references are listed.The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?
Taha Bin Arif
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Pragya D. Yadav et al.
CLINICAL INFECTIOUS DISEASES (2022)
Review Article Genotype and phenotype of COVID-19: Their roles in pathogenesis
Leila Mousavizadeh et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
Kara L. Lynch et al.
CLINICAL INFECTIOUS DISEASES (2021)
Role of the Healthcare Surface Environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Potential Control Measures
Hajime Kanamori et al.
CLINICAL INFECTIOUS DISEASES (2021)
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Saborni Chakraborty et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Pandemics Throughout History
Jocelyne Piret et al.
FRONTIERS IN MICROBIOLOGY (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis et al.
NPJ VACCINES (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai et al.
CELL (2021)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary et al.
LANCET (2021)
MIXING COVID VACCINES TRIGGERS POTENT IMMUNE RESPONSE
Ewen Callaway
NATURE (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
V. Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
Eakachai Prompetchara et al.
PLOS ONE (2021)
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
Yeong Jun Kim et al.
VIRUSES-BASEL (2021)
Wuhan to World: The COVID-19 Pandemic
Ashok Kumar et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The COVID-19 Vaccines: Recent Development, Challenges and Prospects
Yuxin Yan et al.
VACCINES (2021)
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
Nawal Al Kaabi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
SARS-CoV-2 variants of concern are emerging in India
Jasdeep Singh et al.
NATURE MEDICINE (2021)
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins et al.
NATURE MEDICINE (2021)
COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern
Md. Zeyaullah et al.
FRONTIERS IN GENETICS (2021)
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Sonia Jangra et al.
LANCET MICROBE (2021)
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design
Danielle C. Groves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic?
Mayda Gursel et al.
MEDICAL HYPOTHESES (2020)
Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense
Xuhua Xia
MOLECULAR BIOLOGY AND EVOLUTION (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Victor J. Costela-Ruiz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets
Sumit Mukherjee et al.
VACCINES (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model
Refat Khan Pathan et al.
CHAOS SOLITONS & FRACTALS (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
SARS-CoV-2: characteristics and current advances in research
Yicheng Yang et al.
VIROLOGY JOURNAL (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
Ricardo Palacios et al.
TRIALS (2020)
Characterization of accessory genes in coronavirus genomes
Christian Jean Michel et al.
VIROLOGY JOURNAL (2020)
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research
Hongpeng Jia et al.
NATURE COMMUNICATIONS (2020)
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos et al.
NPJ VACCINES (2020)
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
Magda Gioia et al.
BIOCHEMICAL PHARMACOLOGY (2020)
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genome evolution of SARS-CoV-2 and its virological characteristics
So Nakagawa et al.
INFLAMMATION AND REGENERATION (2020)
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J. Hou et al.
SCIENCE (2020)
The Current Status of COVID-19 Vaccines
Kenneth Lundstrom
FRONTIERS IN GENOME EDITING (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
T cell responses in patients with COVID-19
Zeyu Chen et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?
Negro Francesco
SWISS MEDICAL WEEKLY (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Defining trained immunity and its role in health and disease
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2020)
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't
John S. Mackenzie et al.
MICROBIOLOGY AUSTRALIA (2020)
BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
Camila Covian et al.
FRONTIERS IN IMMUNOLOGY (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China
Zhi-Qi Zeng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Surveillance and genetic characterization of rotavirus strains circulating in four states of North Indian children (Publication with Expression of Concern. See vol. 62, 2018)
Mohammad Islamuddin et al.
INFECTION GENETICS AND EVOLUTION (2018)
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection
Rekha Khandia et al.
FRONTIERS IN IMMUNOLOGY (2018)
A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus
Jianping Li et al.
PLOS ONE (2018)
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
Larisa Rudenko et al.
PLOS ONE (2018)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Jingxian Zhao et al.
SCIENCE IMMUNOLOGY (2017)
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Oi-Wing Ng et al.
VACCINE (2016)
Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
Chan-Ki Min et al.
SCIENTIFIC REPORTS (2016)
The mercurial nature of neutrophils: still an enigma in ARDS?
Andrew E. Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity
Johanneke Kleinnijenhuis et al.
JOURNAL OF INNATE IMMUNITY (2014)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines
Rafi Ahmed et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Coronaviruses An RNA proofreading machine regulates replication fidelity and diversity
Mark R. Denison et al.
RNA BIOLOGY (2011)
Disappearance of antibodies to SARS-associated coronavirus after recovery
Wu-Chun Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters
A Roberts et al.
JOURNAL OF VIROLOGY (2005)